美国商业保险儿童中社会劣势与中耳炎治疗的关联
这项横断面研究纳入2003年1月1日至2021年3月31日Optum Clinformatics Data Mart数据库中4 831 408例中耳炎患儿,分析社会剥夺指数与治疗模式的关系。社会剥夺指数较高与复发性中耳炎、化脓性中耳炎药物治疗及鼓膜置管几率降低相关,但与严重并发症几率升高相关。
要点
- 社会剥夺指数较高与复发性中耳炎药物治疗几率降低相关(OR 0.86,95%CI 0.85-0.87)。
- 社会剥夺指数较高与化脓性中耳炎药物治疗几率降低相关(OR 0.61,95%CI 0.60-0.62)。
- 社会剥夺指数较高与鼓膜置管几率降低相关(OR 0.76,95%CI 0.75-0.78),严重并发症几率升高(OR 1.28,95%CI 1.19-1.37)。
核心结论
- 社会劣势的中耳炎患儿接受治疗的可能性较低,因治疗不足而出现并发症的可能性较高。
- 中耳炎是听力损失的可改变危险因素,需要努力确保所有儿童公平获得治疗。
研究设计与样本
- 横断面研究,纳入2003年1月1日至2021年3月31日Optum Clinformatics Data Mart数据库中4 831 408例中耳炎患儿,链接住院、门诊和药品索赔数据。
- 暴露因素包括首次中耳炎诊断年龄、性别、环境过敏、胃食管反流、腺样体扁桃体肥大、邮政编码、社会剥夺指数评分、社会脆弱性指数评分。
- 主要结局为复发性及化脓性中耳炎治疗、鼓膜置管插入及治疗不足所致严重并发症的治疗。
- 采用多元逻辑回归分析量化各变量与研究结局的关联,社会脆弱性指数用于敏感性分析以确保外部效度。
主要发现
- 4 831 408例患儿中位年龄4岁(IQR 1-8岁),男孩2 491 557例(51.57%)。
- 994 921例(20.59%)因复发性中耳炎接受治疗,717 978例(14.86%)因化脓性中耳炎接受治疗,335 949例(6.95%)接受鼓膜置管,10 975例(0.23%)出现中耳炎严重并发症。
- 在多变量回归模型中,诊断年龄较早、男性、环境过敏、胃食管反流及腺样体扁桃体肥大与中耳炎治疗增加相关。
- 社会剥夺指数与复发性中耳炎药物治疗几率降低相关(OR 0.86;95%CI 0.85-0.87)。
- 社会剥夺指数与化脓性中耳炎药物治疗几率降低相关(OR 0.61;95%CI 0.60-0.62),与鼓膜置管几率降低相关(OR 0.76;95%CI 0.75-0.78),与严重并发症几率升高相关(OR 1.28;95%CI 1.19-1.37)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is well established that social disadvantage is associated with earlier, more frequent, and more severe otitis media in children. Appropriate medical and surgical treatment of otitis media can prevent hearing loss and other complications, which may affect future academic and employment opportunities in socially disadvantaged populations. Clinical treatment patterns for otitis media in the US are unclear. OBJECTIVE: To describe and quantify social disparities in the treatment patterns of otitis media in children in the US. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included claims data from the Optum Clinformatics Data Mart Database between January 1, 2003, and March 31, 2021, with linked inpatient, outpatient, and pharmaceutical claims for 4 831 408 children with otitis media. EXPOSURES: Age at first otitis media diagnosis, sex, environmental allergies, gastroesophageal reflux, adenotonsillar hyperplasia, zip code, social deprivation index score, social vulnerability index score. MAIN OUTCOMES AND MEASURES: Treatment of recurrent and suppurative otitis media in children, insertion of tympanostomy tubes, and treatment for severe complications of undertreated otitis media. The principal measure of social disadvantage was the social deprivation index. The social vulnerability index was used for sensitivity analyses to ensure external validity. Multiple logistic regression analyses were used to quantify the association of all projected variables with the study outcomes. RESULTS: Among 4 831 408 US children with otitis media (median [IQR] age, 4 [1-8] years; 2 491 557 boys [51.57%]), 994 921 (20.59%) were treated for recurrent otitis media, 717 978 (14.86%) were treated for suppurative otitis media, 335 949 (6.95%) received tympanostomy tubes, and 10 975 (0.23%) had severe complications of otitis media. In multivariable regression models including patient factors and social indices, earlier age at diagnosis, male sex, environmental allergies, gastroesophageal reflux, and adenotonsillar hyperplasia were associated with increased treatment for otitis media, whereas social deprivation index was associated with lower odds of medical treatment for recurrent otitis media (odds ratio [OR], 0.86; 95% CI, 0.85-0.87), suppurative otitis media (OR, 0.61; 95% CI, 0.60-0.62), and insertion of tympanostomy tubes (OR, 0.76; 95% CI, 0.75-0.78) but higher odds of having severe complications (OR, 1.28; 95% CI, 1.19-1.37). CONCLUSIONS AND RELEVANCE: The findings of this cross-sectional study suggest that children with otitis media who were socially disadvantaged were less likely to receive treatment and more likely to experience complications for undertreated otitis media. As otitis media is a modifiable risk factor for hearing loss, efforts need to be made to ensure equitable access to treatment for all children.
引用
- Qian ZJ, Rehkopf DH. Association Between Social Disadvantage and Otitis Media Treatment in US Children With Commercial Insurance. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 36355356. doi:10.1001/jamaoto.2022.3560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。